These results are consistent with clinical observations that deregulation of ErbB-PI3K signaling elements can elicit distinct responses40 and highlights the ability of this platform to reveal specific morphogenic behaviors associated with distinct breast cancer-associated genetic alterations. The gene discussed is PIK3CA; the disease is breast carcinoma.